These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24367337)

  • 1. Neurocognitive Functioning in Schizophrenia and Bipolar Disorder: Clarifying Concepts of Diagnostic Dichotomy vs. Continuum.
    Kuswanto CN; Sum MY; Sim K
    Front Psychiatry; 2013; 4():162. PubMed ID: 24367337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?
    Kuswanto C; Chin R; Sum MY; Sengupta S; Fagiolini A; McIntyre RS; Vieta E; Sim K
    Neurosci Biobehav Rev; 2016 Feb; 61():66-89. PubMed ID: 26691725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
    Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross diagnostic comparisons of quality of life deficits in remitted and unremitted patients with schizophrenia and bipolar disorder.
    Sum MY; Ho NF; Sim K
    Schizophr Res; 2015 Oct; 168(1-2):191-6. PubMed ID: 26341581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Impairments (NCI) in bipolar disorder: Comparison with schizophrenia and healthy controls.
    Esan O; Oladele O; Adediran KI; Abiona TO
    J Affect Disord; 2020 Dec; 277():175-181. PubMed ID: 32829193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up.
    Jiménez-López E; Sánchez-Morla EM; López-Villarreal A; Aparicio AI; Martínez-Vizcaíno V; Vieta E; Rodriguez-Jimenez R; Santos JL
    Eur Psychiatry; 2019 Feb; 56():60-68. PubMed ID: 30500572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive Endophenotypes of Schizophrenia and Bipolar Disorder and Possible Associations with FKBP Variant rs3800373.
    Memic A; Streit F; Hasandedic L; Witt SH; Strohmaier J; Rietschel M; Oruc L
    Med Arch; 2018 Nov; 72(5):352-356. PubMed ID: 30524168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression.
    Kessler U; Schoeyen HK; Andreassen OA; Eide GE; Hammar Å; Malt UF; Oedegaard KJ; Morken G; Sundet K; Vaaler AE
    BMC Psychiatry; 2013 Apr; 13():105. PubMed ID: 23557429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical activity measured by functional near infrared spectroscopy during a theory of mind task in subjects with schizophrenia, bipolar disorder and healthy controls.
    Sayar-Akaslan D; Baskak B; Kir Y; Kusman A; Yalcinkaya B; Çakmak IB; Munir K
    J Affect Disord; 2021 Mar; 282():329-339. PubMed ID: 33421860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurocognitive functioning in euthymic patients with bipolar type I disorder].
    Dias VV; Brissos S; Martinez-Arán A; Kapczinski F
    Acta Med Port; 2008; 21(6):527-38. PubMed ID: 19331785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Vreeker A; Boks MP; Abramovic L; Verkooijen S; van Bergen AH; Hillegers MH; Spijker AT; Hoencamp E; Regeer EJ; Riemersma-Van der Lek RF; Stevens AW; Schulte PF; Vonk R; Hoekstra R; van Beveren NJ; Kupka RW; Brouwer RM; Bearden CE; MacCabe JH; Ophoff RA;
    Psychol Med; 2016 Mar; 46(4):807-18. PubMed ID: 26621616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia.
    Ohi K; Takai K; Sugiyama S; Kitagawa H; Kataoka Y; Soda M; Kitaichi K; Kawasaki Y; Ito M; Shioiri T
    CNS Spectr; 2021 Mar; ():1-7. PubMed ID: 33731244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A).
    Bauer IE; Keefe RS; Sanches M; Suchting R; Green CE; Soares JC
    J Psychiatr Res; 2015 Jan; 60():81-6. PubMed ID: 25455513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain-processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome?
    Minichino A; Delle Chiaie R; Cruccu G; Piroso S; Di Stefano G; Francesconi M; Bersani FS; Biondi M; Truini A
    Bipolar Disord; 2016 Nov; 18(7):591-601. PubMed ID: 27782355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains.
    Alden EC; Cobia DJ; Reilly JL; Smith MJ
    Schizophr Res; 2015 Oct; 168(1-2):273-8. PubMed ID: 26215505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Italian version of the Brief Assessment of Cognition in Affective Disorders: performance of patients with bipolar disorder and healthy controls.
    Rossetti MG; Perlini C; Abbiati V; Bonivento C; Caletti E; Fanelli G; Lanfredi M; Lazzaretti M; Pedrini L; Piccin S; Porcelli S; Sala M; Serretti A; Bellani M; Brambilla P;
    Compr Psychiatry; 2022 Aug; 117():152335. PubMed ID: 35841657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.